Evidence map›Paper›PMID 25084525›Full record

ArticleThe Biochemical journal2014

Serine/threonine kinase 16 and MAL2 regulate constitutive secretion of soluble cargo in hepatic cells.

Julie G In, Anneliese C Striz, Antonio Bernad, Pamela L Tuma

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Serine/Threonine Protein Kinase STK16.International journal of molecular sciences · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Julie G In*Department of Biology, The Catholic University of America, Washington, DC 20064, U.S.A.
Anneliese C Striz*Department of Biology, The Catholic University of America, Washington, DC 20064, U.S.A.
Antonio Bernad†Department of Regenerative Cardiology, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Melchor Fernández Almagro 3, E-28029 Madrid, Spain.
Pamela L Tuma*Department of Biology, The Catholic University of America, Washington, DC 20064, U.S.A.
University of America · USSpanish National Centre for Cardiovascular Research · ES

Funding

BASIC SCIENCE RESEARCH IN DIGESTIVE DISEASEST32DK007632 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI DONOWITZ, MARK · 1989 to 2018
$5.4M
MAL2 regulation of hepatic protein trafficking: mechanisms and binding partnersR01DK082890 · NIDDK · CATHOLIC UNIVERSITY OF AMERICA · PI TUMA, PAMELA L. · 2009 to 2012
$774k
MAL proteolipids in apical protein delivery in epitheliaR15GM070801 · NIGMS · CATHOLIC UNIVERSITY OF AMERICA · PI TUMA, PAMELA L · 2004 to 2004
$201k
NIDDK NIH HHS DK082890NIDDK NIH HHS R01 DK082890NIDDK NIH HHS T32 DK007632NIGMS NIH HHS GM070801NIGMS NIH HHS R15 GM070801
6 · The paper itself

Abstract

MAL2 (myelin and lymphocyte protein 2) is thought to regulate at least two steps in the hepatic apical transcytotic pathway. As vesicle budding and delivery at each step are driven by complex machineries, we predicted that MAL2 participates in several large protein complexes with multiple binding partners. To identify novel MAL2 interactors, we performed split-ubiquitin yeast two-hybrid assays and identified STK16 (serine/threonine kinase 16) as a putative interactor which we verified morphologically and biochemically. As STK16 is a Golgi-associated constitutively active kinase implicated in regulating secretion and because of the massive constitutive secretory capacity of hepatic cells, we tested whether MAL2 and STK16 function in secretion. Expression of a dominant-negative kinase-dead STK16 mutant (E202A) or knockdown of MAL2 impaired secretion that correlated with decreased expression of albumin and haptoglobin. By using 19°C temperature blocks and lysosome deacidification, we determined that E202A expression or MAL2 knockdown did not interfere with albumin synthesis or processing, but led to albumin lysosomal degradation. We conclude that MAL2 and the constitutively active STK16 function to sort secretory soluble cargo into the constitutive secretory pathway at the TGN (trans-Golgi network) in polarized hepatocytes.

Indexed as

AlbuminsHepatocytesHumansLysosomesMyelin and Lymphocyte-Associated Proteolipid ProteinsProtein BindingProtein Serine-Threonine KinasesProtein TransportTranscription Factorstrans-Golgi NetworkTwo-Hybrid System TechniquesAlbuminsMAL2 protein, humanMyelin and Lymphocyte-Associated Proteolipid ProteinsProtein Serine-Threonine KinasesSTK16 protein, humanTranscription Factors

Identifiers

PMID25084525
PMCPMC4736628
OpenAlexW2316574108

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.